July 1, 2005 (Press Release) --
MDM Group Appoints Chief Executive Officer
MDM Group, Inc. (OTC.PK: MDDM) advises that the Company has appointed Dr. Paul D. Slowey as its Chief Executive Officer, effective immediately. Dr. Slowey is a founding partner of Bamburgh Marrsh LLC which the Company has recently acquired. Bamburgh Marrsh has developed and patented world leading oral diagnostic and screening technologies with application in major markets including clinical, biodefense and substance abuse testing and screening. The substance abuse testing rights are currently in the process of being exclusively licensed to Harrington Group (Australia:HGR.AX) (OTC.PK: HGRLF) subject to their shareholder approval at a General Meeting.
Disclaimer: www.investorideas.com/about/disclaimer
Full News: www.investorideas.com/Companies/ViewDocument.asp?ID=3141
MDM Group, Inc. (OTC.PK: MDDM) advises that the Company has appointed Dr. Paul D. Slowey as its Chief Executive Officer, effective immediately. Dr. Slowey is a founding partner of Bamburgh Marrsh LLC which the Company has recently acquired. Bamburgh Marrsh has developed and patented world leading oral diagnostic and screening technologies with application in major markets including clinical, biodefense and substance abuse testing and screening. The substance abuse testing rights are currently in the process of being exclusively licensed to Harrington Group (Australia:HGR.AX) (OTC.PK: HGRLF) subject to their shareholder approval at a General Meeting.
Disclaimer: www.investorideas.com/about/disclaimer
Full News: www.investorideas.com/Companies/ViewDocument.asp?ID=3141

MDM Group, Inc. (OTC.PK: MDDM) advises that the Company has appointed Dr. Paul D. Slowey as its Chief Executive Officer, effective immediately.
Email
Print
SPAM




